Back to BANK OF MONTREAL /CAN/ BANK OF MONTREAL /CAN/

ONCYONCY
Showing 8 of 23 quarters

Position history for BANK OF MONTREAL /CAN/BANK OF MONTREAL /CAN/'s holdings in ONCOLYTICS BIOTECH INC

As of its Q1 2026 13F, Bank of Montreal held 44,484 shares of ONCY (Oncolytics Biotech), worth $37,758. Bank of Montreal's 13F filings listed ONCY from Q4 2020 to Q1 2026, 22 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$33,645

Total Shares Change

-37,924

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.95
0
2026-Q1
Increased
44,484
+16.0%
$37,7580.0%$0.85
16
2025-Q4
Increased
38,336
+0.3%
$24,4110.0%$0.87
13
2025-Q3
Decreased
38,211
-1.4%
$53,4950.0%$1.40
0
2025-Q2
Decreased
38,736
-1.1%
$29,6030.0%$0.77
0
2025-Q1
Decreased
39,168
-0.2%
$21,5060.0%$0.55
0
2024-Q4
Increased
39,231
+3.5%
$36,2520.0%$0.91
14
2024-Q3
Increased
37,924
+1.3%
$33,6450.0%$0.87
14

Other major holders of ONCY: Verition Fund Management LLC, Creative Planning, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used